The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
10.1016/j.esmoop.2021.100144
Saved in:
Main Authors: | Ngoi, NYL, Tan, DSP |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/191316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
by: Leary, A, et al.
Published: (2021) -
Construction of chimeric cyclodextrin glucanotransferases by homologous recombination and study of their activites
by: Anusak Keadsin
Published: (2006) -
The role of ChvG in regulating homologous recombination in Agrobacterium
by: WANG LONG
Published: (2010) -
Intromolecular homologous recombination of linearized plasmids in Escherichia coli K12
by: Chua, K.L., et al.
Published: (2013) -
Poly(adenosine diphosphate-ribose) polymerase expression in human traumatic brain injury
by: Ang, B.T., et al.
Published: (2014)